| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Major pollen allergen Bet v 1-A, Allergen Bet v I-A, Bet v 1-A, BETVIA, BETVI. |
| Expression System | |
| Form | Sterile Filtered clear solution. |
| Formulation | |
| Product Type | |
| Purity | |
| Source | Sf9 insect cells. |
| Storage | |
| Target |
Recombinant Major Pollen Allergen Bet v 1-A, Sf9 is supplied as a recombinant protein for in vitro research use.
Background
Major pollen allergen Bet v 1-A (Bet v 1.0101) causes an allergic reaction in humans. Bet v 1.0101 is a cause of type I allergic reactions in Europe, North America and the former Soviet Union states, observed in early spring.
Product format
Provided as a recombinant protein suitable for in vitro workflows such as binding studies, screening, and assay development. Refer to the specifications table for expression format and molecular properties.
Activity & assay information
-
Immunological functions: 1. Binds IgE type human antibodies.
2. Immunodot test with positive/negative sera panels.
What is the purity of Recombinant Major Pollen Allergen Bet v 1-A, Sf9?
What buffer / formulation is this protein supplied in?
How should Recombinant Major Pollen Allergen Bet v 1-A, Sf9 be stored?
What expression system was used to produce this protein?
Is this protein approved for clinical or in vitro diagnostic use?
Can I request a custom size, tag variant, or formulation?
Can’t Find What You’re Looking For? We can help you source the best match or customize a recombinant protein solution for your study. Options may include species (human/mouse/rat), protein region/domain (full-length vs fragment), tag or label (His/GST/FLAG/biotin/fluorescent), expression system (E. coli/HEK293/insect), purity grade, formulation (buffer, carrier-free, glycerol-free), activity/functional validation (binding or enzymatic assays), endotoxin level (low-endotoxin for cell-based work), mutants/variants (point mutations, isoforms), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.